Home
>>
Products
>>
Antibodies
>>
Recombinant Antibodies
>
Anti-Human EGFR Recombinant Antibody(Cetuximab)

Anti-Human EGFR Recombinant Antibody(Cetuximab)

Product Number

YR1089

Alias

科研级 Cetuximab ( 西妥昔单抗 ), Anti-EGFR Recombinant Antibody, Research Grade Cetuximab

Specifications
  • 1mg
  • 5mg
Product Description
Alias科研级 Cetuximab ( 西妥昔单抗 ), Anti-EGFR Recombinant Antibody, Research Grade Cetuximab
Catalog NumberYR1089
Molecular NameCetuximab
Size1mg, 5mg
ClonityMonoclonal
Purity>95% as determined by SDS-PAGE
Concentration1mg/ml
Antibody IsotypeIgG1 Kappa
FormulationPBS, pH7.5
BackgroundCetuximab is an epidermal growth factor receptor (EGFR) inhibitor medication used for the treatment of metastatic colorectal cancer and head and neck cancer. Cetuximab is a chimeric (mouse/human) monoclonal antibody given by intravenous infusion that is distributed under the trade name Erbitux in the U.S. and Canada by the drug company Eli Lilly and Co.
CAS Number205923-56-4
ApplicationIF, IP, Neut, FuncS, ELISA, FCM
Storage ConditionIt is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
RemarksThis product is for research use only.
Shipping ConditionShipped on ice packs.
Molecular Weight145.78 kDa
TargetEGFR[Homo sapiens]

Login

Don’t have an account?Sign Up Now

Register

Already have an account?Log In Now

Inquire Now